Chinese medicinal preparation for treating viral myocarditis

Abstract

The invention discloses a Chinese medicinal preparation for treating viral myocarditis, which is prepared from the following raw materials in part by weight: 30 to 60 parts of ligularia japonica, 25 to 50 parts of many-headed savory, 20 to 40 parts of honeysuckle flower, 20 to 40 parts of isatis indigotica fort, 15 to 30 parts of scutellaria laterifolia, 15 to 30 parts of cortex moutan, 12 to 24 parts of gardenia fruit, 20 to 40 parts of danshen root, 10 to 20 parts of bamboo leaf and 6 to 18 parts of mix-fried liquoric root. The Chinese medicinal preparation for preventing and curing the viral myocarditis has the effects of soothing sinews and quickening network vessels, dissipating stasis and relieving noxious gas, diminishing inflammation, relieving pain, improving disease resistance of bodies, dilating blood vessels and improving arterial blood circulation, and has exact curative effect of preventing and curing the viral myocarditis. The Chinese medicinal preparation has the effective rate of 100 percent and the cure rate of 94 percent when taken in 60 days for the general viral myocarditis.

Description

technical field [0001] The invention relates to a traditional Chinese medicine preparation, in particular to a traditional Chinese medicine preparation for treating viral myocarditis. Background technique [0002] Viral myocarditis refers to the diffuse or limited inflammation of the myocardium caused by various viral infections. In recent years, the incidence rate has increased significantly, and viruses have become the most important pathogenic factor of myocarditis. Viral myocarditis is more common in children and young adults, and it is not uncommon in elderly patients. [0003] Viral myocarditis involves a wide range of areas, especially for adolescents and children, and many elderly people are no exception. They occur to varying degrees, so they are universal. [0004] Almost all groups of viruses can cause myocarditis, but respiratory and enteroviruses are the most common, among which coxsackie virus B is the most important, accounting for 40-45% of all myocarditis, ...

AI Technical Summary

Problems solved by technology

[0006] At present, there is no special drug for the treatment of viral myocarditis on the market. Similar drugs for the treatment of this disease, such as adenosine triphosphate, coenzyme A, cytochrome C, inosine, vitamin C, etc., do not significantly improve the symptoms after taking it, let alone have the ability to treat it. function of healing